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ABSTRACT
Exposure to estrogens and alcohol consumption - the two only well-established 
risk factors for breast cancer - are capable of causing oxidative stress, which has been 
linked to progression of breast cancer. Here, five functional polymorphisms in the 
antioxidant genes SOD1, CAT and GSR were investigated in 703 breast cancer case-
control pairs in the Danish, prospective “Diet, Cancer and Health” cohort together with 
gene-environment interactions between the polymorphisms, enzyme activities and 
intake of fruits and vegetables, alcohol and smoking in relation to breast cancer risk. 
Our results showed that genetically determined variations in the antioxidant enzyme 
activities of SOD1, CAT and GSR were not associated with risk of breast cancer per se. 
However, intake of alcohol, fruit and vegetables, and smoking status interacted with 
some of the polymorphisms in relation to breast cancer risk. Four polymorphisms were 
strongly associated with enzyme activity, but there was no interaction between any of 
the studied environmental factors and the polymorphisms in relation to enzyme activity. 
Additionally, single measurement of enzyme activity at entry to the cohort was not 
associated with risk of breast cancer. Our results therefore suggest that the antioxidant 
enzyme activities studied here are not major determinants of breast cancer risk.
INTRODUCTION
Breast cancer (BC) is the most common type of 
cancer in Denmark among women and the second leading 
cause of cancer death after lung cancer [1]. The incidence 
has increased during the last decade [1], which warrants 
further knowledge about the underlying mechanisms. 
Environmental factors, in interplay with genetics, are known 
to be important in the etiology of BC [2–5]. Therefore, 
examining gene-environment interactions is an effective 
tool for identifying biological pathways in disease etiology.
The only well-established risk factors for BC are 
associated with prolonged exposure to estrogens [6,7] and 
alcohol consumption [8–10]. Both exposure to estrogens and 
alcohol consumption are capable of causing oxidative stress 
[reviewed in 11], which has also been linked to progression 
of cancer, including BC [12–18]. Oxidative stress is caused 
by an imbalance between the generation of reactive oxygen 
species (ROS), such as superoxide anions, hydrogen 
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peroxide and hydroxyl radicals, and the antioxidant defense, 
including various enzymes and high and low molecular 
weight antioxidants (including glutathione (GSH)), leading 
to DNA damage, lipid peroxidation and protein oxidation. 
An efficient antioxidant defense will limit oxidative damage 
by ensuring a reducing environment [19,20]. The enzymatic 
antioxidant defense system is complex and may be described 
as an interacting network of several enzymes, including 
glutathione reductase (GR), superoxide dismutase (SOD) 
and catalase (CAT). Where GR catalyzes the reduction of 
GSH, an important antioxidant, superoxide anion radicals 
are dismutated by SOD to hydrogen peroxide. CAT converts 
hydrogen peroxide to water and oxygen, thereby preventing 
formation of the highly reactive hydroxyl radical. BC may 
partly be caused by oxidative damage combined with a failure 
of antioxidants to protect the breast tissue [14]. Smoking and 
alcohol consumption are sources of ROS whereas fruit and 
vegetables are rich in dietary antioxidants. Furthermore, 
several studies have indicated that an increased intake of 
fruits and vegetables may affect the enzymatic antioxidant 
defense system, leading to increased enzyme activities [21–
24]. These dietary and life style choices may modulate risk of 
BC by altering the level of oxidative stress, such that alcohol 
consumption and smoking increase the risk, while intake of 
fruit and vegetables decreases the risk. However, where meta-
analyses have not provided consisting evidence of an inverse 
association between intake of fruit and vegetables and BC 
risk on one side [25–29], and positive association between 
smoking and BC risk on the other side [reviewed in 30], 
interactions between smoking, alcohol consumption, fruit and 
vegetable intake, and polymorphisms in antioxidant genes 
in relation to BC risk, have been reported [30–34]. Thus, 
genetically determined variations in the activities of enzymes 
that protect against or generate oxidative stress could modify 
associations between dietary antioxidants and exogenous 
sources of ROS, and BC risk, and thus explain some of the 
inconsistencies in the results from these studies. Additionally, 
lower antioxidant enzyme activities in BC patients compared 
to healthy controls have been reported in several studies 
[35–38]. Prospective cohort studies may reveal whether these 
lowered activities are a cause or consequence of the disease in 
combination with examination of dietary and life style factors 
and their interaction with the enzymes in relation to risk of 
disease.
Functional polymorphisms may impact the enzymatic 
activities leading to altered antioxidant defense and thereby 
affect disease risk and health. We have previously found 
associations between functional polymorphisms in GPX1 
and GPX4 genes, erythrocyte GPX activity, alcohol intake, 
hormone replacement therapy (HRT) use and BC risk in the 
Danish “Diet, Cancer and Health” (DCH) cohort [31,39]. In 
the present study, we wanted to extend these findings with 
polymorphisms in the antioxidant genes SOD1 (encoding 
SOD), CAT (encoding CAT) and GSR (encoding GR) in 
a study group of 975 postmenopausal women with BC 
and 975 matched controls nested within the DCH cohort; 
and search for gene-environment interactions between the 
polymorphisms, enzyme activities and intake of fruits and 
vegetables, alcohol and smoking in relation to BC risk.
RESULTS
Baseline characteristics of BC cases and 
matched controls are presented in Table 1. Findings 
regarding the included risk factors have been reported 
previously for the whole DCH cohort, for a subset 
of the present study, and for the present study group 
[31,40–47]. Among controls, the genotype distribution 
of the polymorphisms did not deviate from Hardy-
Weinberg equilibrium (results not shown). None of the 
polymorphisms were significantly associated with risk 
of BC per se (Table 2); however, a tendency towards 
increased risk among variant carriers of the SOD1/
rs202445 polymorphism, was observed (P=0.06). Only 
GSR/rs1002149 interacted weakly with alcohol intake 
in relation to risk of BC such that variant T-carriers had 
a 24% increased risk of BC per 10 g alcohol/day (95% 
CI: 1.09-1.42), whereas wild-type GG-carriers did not 
display alcohol-related modification of BC risk (P-value 
for interaction (Pint)= 0.048) (Table 3). We also found 
interaction between SOD1/rs202445 and intake of fruits 
and vegetables in relation to risk of BC (Pint=0.016) 
(Table 4). Carriage of the variant G-allele of SOD1/
rs202445 was associated with a 13% increased risk of 
BC (95% CI: 1.03-1.25), whereas wild-type AA-carriers 
showed no modified risk of BC per 100 g fruits and 
vegetables per day (Table 4). Smoking status interacted 
with the CAT/rs1001179 polymorphism in relation to 
risk of BC (Pint=0.0015) (Table 5). Variant A-carriers 
of the polymorphism, who did not smoke, had a 41% 
increased risk of BC (95% CI: 1.07-1.87) compared to 
non-smoking wild-type GG-carriers (Table 5).
Activities of CAT, SOD and GR enzymes were 
measured in a subset of the cohort at the time of entry 
into the DCH cohort (n=434 cases and 434 controls). In 
linear analysis (Table 6), increment in enzyme activity 
of the three enzymes was associated with statistically 
non-significant decreased risk of BC (IRRCAT=0.89, 
95% CI: 0.75-1.06; IRRSOD=0.94, 95% CI: 0.79-1.12; 
IRRGR=0.83, 95% CI: 0.68-1.02). However, in the 
tertile analyses of the enzyme activity (Table 6), only 
increasing CAT activity exhibited a dose-dependent 
decrease in BC risk. In Table 7, the correlation between 
intake of fruit and vegetables, alcohol and smoking, and 
enzyme activity was investigated. A negative correlation 
between alcohol intake and GR activity was found 
(P=0.043) (Table 7). Smoking and intake of alcohol 
were positively correlated with SOD activity with 
marginally statistical significance (Palcohol=0.050 and 
Ppresent smokers=0.054) (Table 7). None of the investigated 
lifestyle factors were associated with CAT activity. In 
Table 8 , the relation between the studied genotypes and 
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enzyme activities was examined. CAT/rs1001179, CAT/
rs12270780 and GSR/rs1002149 polymorphisms were 
strongly associated with enzyme activities (P≤0.0001 
for all three single nucleotide polymorphisms (SNPs)) 
among both cases and controls, so that enzyme 
activities increased for each variant allele for CAT/
rs12270780 and GSR/rs1002149, whereas enzyme 
activities decreased for CAT/rs1001179 for each variant 
allele (Table 8). CAT/rs769217 polymorphism was also 
associated with enzyme activity (Pall=0.0007) with 
enzyme activities decreasing for each variant allele, but 
only among controls (Pcontrols=0.0007 and Pcases=0.25) 
(Table 8). These associations were not significantly 
modified by intake of alcohol, fruits and vegetables, and 
smoking status (Pint between 0.26-0.92 (Supplemental 
Table 1 )). We have previously found association 
between HRT use and GPX activity [39], but in the 
present study, we did not find indication of association 
between CAT, SOD or GR enzyme activities and HRT 
use (Supplemental Table 2 ). Haplotype analysis of CAT 
polymorphisms revealed that haplotypes encompassing 
variant alleles of CAT/rs1001179 and CAT/rs769217, 
respectively, were functional, and that haplotypes 
encompassing the variant allele of CAT/rs1001179 had 
the strongest effect on CAT enzyme activity (Table 9).
We found an increased risk of BC among women 
carrying both the low activity A-allele of CAT/rs1001179 
and high activity G-allele of SOD1/rs202445 (IRR: 
1.43; 95% CI: 1.01-2.01) (Table 10). The interaction 
was, however, not significant on a multiplicative scale 
(Pint=0.27), but could be considered additive. We also 
investigated other combinations of polymorphisms in 
relation to risk of BC, but did not find anything further 
(results not shown).
Table 1: Baseline characteristics of the DCH study participants by selected demographic and established BC risk factors
Variable Cases Controls IRRa (95% CI)
n (%) Median (5-95%) n (%) Median (5-95%)
Women 703 (100) 703 (100)
Age at inclusion, years 57 (51-64) 57 (51-64)
School education
  Short
  Medium
  Long
206 (29)
353 (50)
144 (20)
250 (36)
313 (45)
122 (17)
1.0 (ref.)
1.19 (0.92-1.54)
1.27 (0.90-1.78)
Body mass index, kg/
m2
25 (20-34) 25 (20-34) 1.02 (0.97-1.08)b
Nulliparous 104 (15) 82 (12) 1.02 (0.65-1.58)c
Number of births 2 (1-4) 2 (1-4) 0.92 (0.79-1.05)
Age at first birth, years 24 (18-31) 23 (18-32) 1.06 (0.91-1.24)d
Use of HRT, yearse 6 (0.5-20) 5 (0.5-20) 1.00 (0.87-1.15)f
Abstainers 18 (3) 22 (3) 0.92 (0.47-1.79)g
Alcohol intake, g/day 11 (1-43) 9 (1-40) 1.11 (1.03-1.20)h
Present smokers 241 (34) 264 (38) 0.93 (0.73-1.19)
Total fruit and 
vegetable intake, g/day
361 (118-785) 349 (108-819) 1.02 (0.97-1.08)i
Benign breast disease 139 (20) 88 (13) 1.64 (1.22-2.20)
Values are expressed as medians (5th and 95th percentiles) or as fractions (%). IRR: incidence rate ratio.
a The risk estimates for BC are mutually adjusted.
b The risk is estimated per additional 2 kg/m2.
c The risk is estimated for nulliparous versus one birth at age 35.
d The risk is estimated per additional 5 years.
e Among ever users of HRT.
f The risk is estimated per additional 5-year of HRT use.
g The risk for abstainers compared to the increment of 10 g alcohol per day.
h Among drinkers, risk estimate is estimated for the increment of 10 g alcohol per day.
i The risk is estimated per additional 100 g intake fruit and vegetables per day.
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DISCUSSION
In the present study, we found that genetically 
determined variations in the antioxidant enzyme 
activities of CAT, GSR and SOD1 were not 
associated with risk of BC per se in this relatively 
large cohort. However, intake of alcohol, fruit and 
vegetables, and smoking status interacted with some 
of the polymorphisms in relation to BC risk. All 
polymorphisms, except for SOD1/rs202445, were 
associated with enzyme activity, but there was no 
interaction between any of the studied environmental 
factors and polymorphisms in relation to enzyme 
activity. Haplotype analysis of CAT polymorphisms 
revealed that CAT/rs1001179 had the strongest effect on 
CAT enzyme activity. Additionally, single measurement 
of enzyme activity at entry to the cohort was not 
associated with risk of BC.
Both in vivo [48–50] and in vitro [49] studies have 
shown that alcohol is capable of decreasing GR activity 
and protein levels in rat breast [48], liver [49] and brain 
tissue [50]. The present study supports these findings, 
since intake of alcohol is associated with decreased 
overall GR enzyme activity and increased risk of BC 
among carriers of the high activity T-variant allele of 
the GSR/rs1002149 polymorphism. Carriage of the 
variant allele of this polymorphism is associated with 
statistically non-significant decreased risk of BC per se, 
indicating that alcohol may inhibit GR activity in the 
variant enzyme. However, alcohol did not interact with 
GSR/rs1002149 in relation to enzyme activity in the 
present study. It is well-known that alcohol consumption 
increases oxidative stress [51,52] and in vitro studies have 
shown that acetaldehyde (the product of the first step in 
alcohol oxidation) can interact with GSH spontaneously 
[53] (forming a GSH-acetaldehyde conjugate). Although 
Table 2: IRR for BC in relation to the studied polymorphisms
Gene SNP ncases (%) 
(n=703)
ncontrols (%) 
(n=703)
IRRa (95% CI) IRRb (95% CI) P-valuec
CAT rs1001179
GG
GA
AA
GA+AA
408 (58)
251 (36)
44 (6)
295 (42)
409 (58)
253 (36)
41 (6)
294 (42)
1.00 (ref.)
1.00 (0.81-1.25)
1.08 (0.69-1.70)
1.02 (0.83-1.25)
1.00 (ref.)
1.05 (0.87-1.32)
1.07 (0.67-1.70)
1.06 (0.85-1.31)
0.65
0.79
0.62
CAT rs12270780
GG
GA
AA
GA+AA
393 (56)
267 (38)
43 (6)
310 (44)
405 (58)
267 (38)
31 (4)
298 (42)
1.00 (ref.)
1.02 (0.82-1.27)
1.37 (0.85-2.19)
1.06 (0.86-1.31)
1.00 (ref.)
1.01 (0.80-1.26)
1.29 (0.80-2.09)
1.04 (0.84-1.29)
0.96
0.30
0.73
CAT rs769217
CC
CT
TT
CT+TT
454 (65)
222 (32)
27 (4)
249 (35)
460 (65)
211 (30)
32 (5)
243 (35)
1.00 (ref.)
1.06 (0.84-1.34)
0.87 (0.50-1.51)
1.04 (0.83-1.30)
1.00 (ref.)
1.06 (0.83-1.35)
0.97 (0.55-1.71)
1.05 (0.83-1.32)
0.64
0.91
0.69
GSR rs1002149
GG
GT
TT
GT+TT
480 (68)
201 (29)
22 (3)
223 (32)
452 (64)
225 (32)
26 (4)
251 (36)
1.00 (ref.)
0.85 (0.68-1.06)
0.80 (0.44-1.45)
0.84 (0.68-1.05)
1.00 (ref.)
0.86 (0.68-1.09)
0.84 (0.46-1.55)
0.86 (0.69-1.08)
0.21
0.58
0.19
SOD1 rs202445
AA
AG
GG
AG+GG
460 (65)
214 (30)
29 (4)
243 (35)
490 (70)
193 (27)
20 (3)
213 (30)
1.00 (ref.)
1.18 (0.93-1.50)
1.56 (0.86-2.80)
1.22 (0.97-1.53)
1.00 (ref.)
1.22 (0.96-1.56)
1.55 (0.85-2.84)
1.25 (0.99-1.59)
0.11
0.15
0.06
IRR: incidence rate ratio.
a Crude.
b Adjusted for parous/nulliparous, number of births, age at first birth, length of school education (low, medium, high), 
duration of HRT use (years), BMI (kg/m2) , previous benign breast disease and alcohol intake (10 g/day).
c P-value for the adjusted risk estimates.
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Table 3: IRR for BC in relation to the studied polymorphisms per increment of 10 g alcohol per day among current 
drinkersa
Gene SNP ncases (%) (n=664) ncontrols (%) (n=664) IRRb (95% CI) IRRc (95% CI) P-valued
CAT rs1001179
GG
GA+AA
382 (58)
282 (42)
388 (58)
276 (42)
1.16 (1.05-1.27)
1.09 (0.96-1.24)
1.15 (1.04-1.26)
1.07 (0.94-1.22) 0.43
CAT rs12270780
GG
GA+AA
375 (56)
289 (44)
384 (58)
280 (42)
1.12 (1.02-1.23)
1.15 (1.02-1.30)
1.11 (1.00-1.22)
1.13 (1.00-1.28) 0.77
CAT rs769217
CC
CT+TT
430 (65)
234 (35)
434 (65)
230 (35)
1.17 (1.06-1.29)
1.08 (0.96-1.21)
1.15 (1.04-1.27)
1.07 (0.95-1.20) 0.34
GSR rs1002149
GG
GT+TT
456 (69)
208 (31)
424 (64)
240 (36)
1.06 (0.97-1.17)
1.27 (1.12-1.45)
1.05 (0.96-1.16)
1.24 (1.09-1.42) 0.048
SOD1 rs202445
AA
AG+GG
436 (66)
228 (34)
463 (70)
201 (30)
1.15 (1.06-1.26)
1.08 (0.94-1.24)
1.14 (1.04-1.25)
1.06 (0.92-1.23) 0.42
IRR: incidence rate ratio.
a 39 case-control pairs were excluded from this analysis due to one participant (or both) in the case-control pair was/(were) 
abstainer(s).
b Crude.
c Adjusted for parity (parous/nulliparous, number of births, age at first birth), length of school education (low, medium, 
high), duration of HRT use (years), previous benign breast disease and BMI (kg/m2) at baseline.
d P-value for interaction for adjusted risk estimates.
Table 4: IRR for BC in relation to the studied polymorphisms per increment of 100 g fruit and vegetables per day
Gene SNP ncases (%) (n=703) ncontrols (%) (n=703) IRRa (95% CI) IRRb (95% CI) P-valuec
CAT rs1001179
GG
GA+AA
408 (58)
295 (42)
409 (58)
294 (42)
1.00 (0.93-1.07)
1.05 (0.98-1.13)
1.00 (0.93-1.07)
1.05 (0.98-1.13) 0.32
CAT rs12270780
GG
GA+AA
393 (56)
310 (44)
 
405 (58)
298 (42)
1.02 (0.95-1.08)
1.04 (0.97-1.12)
1.01 (0.94-1.07)
1.06 (0.98-1.14) 0.33
CAT rs769217
CC
CT+TT
454 (65)
249 (35)
460 (65)
243 (35)
1.05 (0.99-1.11)
0.99 (0.91-1.07)
1.05 (0.99-1.12)
0.98 (0.90-1.07) 0.22
GSR rs1002149
GG
GT+TT
480 (68)
223 (32)
452 (64)
251 (36)
1.01 (0.95-1.07)
1.06 (0.98-1.15)
1.01 (0.95-1.07)
1.07 (0.99-1.16) 0.21
SOD1 rs202445
AA
AG+GG
460 (65)
243 (35)
490 (70)
213 (33)
0.99 (0.93-1.05)
1.13 (1.03-1.24)
0.98 (0.93-1.05)
1.13 (1.03-1.25) 0.016
IRR: incidence rate ratio.
a Crude.
b Adjusted for parity (parous/nulliparous, number of births, age at first birth), length of school education (low, medium, 
high), duration of HRT use (years), previous benign breast disease, alcohol intake (10 g/day) and BMI (kg/m2) at baseline.
c P-value for interaction for adjusted risk estimates.
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this may explain only a minor proportion of observed 
GSH reduction after acute ethanol intoxication, it is not 
clear whether such effects are seen at moderate alcohol 
intake and to what extent this affects GSH availability in 
breast tissue. A possible inhibitory action of ethanol and/
or acetaldehyde on enzymes involved in GSH synthesis 
has also been hypothesized [48,53]. GSH is critical in 
maintaining a reduced cellular environment and plays 
an important role in detoxification processes, including 
removal of peroxides. Potential GSH depletion combined 
with impaired GR enzyme activity may impact antioxidant 
defense, leading to increased carcinogenic potential in the 
breast tissue. We observed previously that alcohol intake 
also influences glutathione peroxidase by increasing the 
activity only in wild-type carriers of the GPX1 gene and 
that the GPX1 Pro198Leu polymorphism may increase 
BC risk [31]. GSH availability seems therefore potentially 
important for BC in accordance with the current findings 
regarding GR.
We were not able to identify other studies examining 
the relationship between SOD1 polymorphism, BC risk 
and potential effect modification by intake of fruit and 
vegetables. Results from studies investigating the effect 
of increased intake of fruit and vegetables on SOD 
activity are inconsistent and the reported effects probably 
depend both on the presence of specific compounds in 
the investigated fruit and vegetables as well as the study 
population. Both negative [54], positive [55,56] and no 
[23] effects of intake of specific (or combinations of) 
fruits and vegetables on SOD enzyme activity have been 
reported. Our results indicate that fruit and vegetables 
consumption may affect BC risk differently in carriers 
of the variant allele of SOD1 polymorphism compared 
to wild-type carriers. Per 100 g increment in fruit and 
vegetable intake, risk of BC increased significantly 
among variant allele carriers only. The reason for this is 
not clear, but if fruit and vegetables increase SOD activity, 
this could potentially lead to increased formation of the 
highly reactive hydroxyl radicals, leading to oxidative 
damage and increased risk of BC if not metabolized to less 
reactive compounds. The increased risk of BC observed in 
carriers of both the high-activity SOD1 and low-activity 
CAT (rs1001179) allele could support this explanation. 
However, whether this is a plausible explanation awaits 
further studies in larger populations with higher intakes of 
fruit and vegetables.
Our finding regarding the association between CAT/
rs1001179 and decreased CAT enzyme activity is consistent 
with two other studies [33,57]. Compared to the other 
studied CAT polymorphisms (CAT/rs12270780 and CAT/
rs769217), CAT/rs1001179 is associated with the largest 
decline in enzyme activity among 743 postmenopausal 
women in the present study. This is also shown in the 
haplotype analysis (Table 9) where the variant allele of 
CAT/rs1001179 is only present on the AGC haplotype 
which is associated with the largest decrease in CAT 
Table 5: IRR for BC in relation to the studied polymorphisms and smoking status (present/non-smoker)
Gene SNP Non-
smokers
ncases/ncontrols
Present 
smokers
ncases/ncontrols
Non-smokers
IRRa  
(95% CI)
Present smokers
IRRa (95% CI)
Non-smokers
IRRb (95% CI)
Present 
smokers
IRRb (95% CI)
P-valuec
CAT rs1001179
GG
GA+AA
264/279
198/160
144/130
97/134
1.00 (ref.)
1.35 (1.03-1.77)
1.19 (0.89-1.61)
0.78 (0.56-1.07)
1.00 (ref.)
1.41 (1.07-1.87)
1.26 (0.92-1.73)
0.83 (0.59-1.17) 0.0015
CAT rs12270780
GG
GA+AA
258/251
204/188
135/154
106/110
1.00 (ref.)
1.04 (0.80-1.35)
0.86 (0.64-1.15)
0.93 (0.66-1.30)
1.00 (ref.)
1.02 (0.78-1.33)
0.89 (0.65-1.21)
0.96 (0.67-1.36) 0.80
CAT rs769217
CC
CT+TT
306/281
156/158
148/179
93/85
1.00 (ref.)
0.91 (0.69-1.20)
0.75 (0.57-1.00)
1.01 (0.73-1.41)
1.00 (ref.)
0.93 (0.70-1.24)
0.80 (0.59-1.08)
1.05 (0.74-1.50) 0.14
GSR rs1002149
GG
GT+TT
322/288
140/151
158/164
83/100
1.00 (ref.)
0.81 (0.61-1.07)
0.84 (0.63-1.11)
0.76 (0.54-1.06)
1.00 (ref.)
0.82 (0.61-1.10)
0.87 (0.65-1.17)
0.81 (0.57-1.16) 0.61
SOD1 rs202445
AA
AG+GG
314/306
148/133
146/184
95/80
1.00 (ref.)
1.10 (0.83-1.46)
0.80 (0.61-1.04)
1.16 (0.81-1.66)
1.00 (ref.)
1.14 (0.85-1.53)
0.84 (0.63-1.12)
1.24 (0.85-1.81) 0.29
IRR: incidence rate ratio.
a Crude.
b Adjusted for parity (parous/nulliparous, number of births, age at first birth), length of school education (low, medium, high), duration of 
HRT use (years), previous benign breast disease, alcohol intake (10 g/day) and BMI (kg/m2) at baseline.
c P-value for interaction for adjusted risk estimates.
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enzyme activity. Studies on BC risk, however, have mostly 
failed to find associations between BC and CAT/rs1001179 
per se [reviewed in 54]. In the present study, high CAT 
enzyme activity was associated with non-significantly 
lowered BC risk, and variant allele carriers of CAT/
rs1001179 were at non-significantly increased BC risk.
We found interaction between CAT/rs1001179 
and smoking status in relation to BC. Among non-
smokers, genetically determined lower CAT activity was 
associated with increased risk of BC, whereas among 
smokers, homozygous wild-type allele carriers were at 
non-significantly increased risk. Smoking was though 
Table 6: Risk of BC in relation to enzyme activity
Enzyme activity (U/g Hb) Cases (n=375) Controls (n=375) IRR (95% CI)a IRR (95% CI)b P-value
n (%) n (%)
CAT activityc 13.8 (10.6-17.3)f 13.7 (10.5-17.6)f 0.93 (0.79-1.10) 0.89 (0.75-1.06) 0.20
CAT activity for tertilesg
≤12.8
>12.8-14.4
>14.4
125 (33)
128 (34)
122 (33)
119 (32)
121 (32)
135 (36)
1.00 (ref.)
0.99 (0.68-1.45)
0.78 (0.52-1.17)
1.00 (ref.)
0.93 (0.63-1.38)
0.72 (0.47-1.10)
0.72
0.13
SOD activityd 840 (643-1071)f 832 (658-1082)f 0.97 (0.82-1.15) 0.94 (0.79-1.12) 0.49
SOD activity for tertilesg
≤795
>795-900
>900
126 (34)
126 (34)
123 (33)
142 (38)
104 (28)
129 (34)
1.00 (ref.)
1.51 (0.99-2.59)
1.10 (0.70-1.74)
1.00 (ref.)
1.51 (0.97-2.35)
1.00 (0.62-1.61)
0.070
0.99
GR activitye 11.4 (9.3-14.0)f 11.5 (9.5-14.5)f 0.83 (0.68-1.01) 0.83 (0.68-1.02) 0.080
GR activity for tertilesg
≤10.8
>10.8-12.2
>12.2
128 (34)
126 (34)
121 (32)
127 (34)
122 (33)
126 (34)
1.00 (ref.)
1.00 (0.69-1.45)
0.95 (0.65-1.37)
1.00 (ref.)
1.01 (0.69-1.47)
0.97 (0.66-1.42)
0.97
0.86
Values are expressed as medians with 5th and 95th percentiles. 59 case-control pairs were excluded because one or both 
in the matched set had missing data on one or more of the potential confounding variables and/or enzyme activities. IRR, 
incidence rate ratio.
a Crude estimates.
b The risk estimates for BC are adjusted for parous/nulliparous, number of births, age at first birth, length of school 
education (low, medium, high), duration of HRT use (years), BMI (kg/m2) , previous benign breast disease and alcohol 
intake (10 g/day).
c Estimates are per increment in activity of 2 U/g Hb.
d Estimates are per increment in activity of 100 U/g Hb.
e Estimates are per increment in activity of 2 U/g Hb.
f Median (5-95%) levels of enzyme activity (U/g Hb) for cases and controls.
g Categories are based on tertiles among both cases and controls.
Table 7: Associations between erythrocyte enzyme activity and dietary and lifestyle factors
Dietary and lifestyle 
factors
CAT activity U/g Hb P-value SOD activity 
U/g Hb
P-value GR activity U/g Hb P-value
Alcohol, per 10 g/
day
+0.029 0.56 -5.70 0.050 -0.071 0.043
Fruit and vegetables, 
per 100 g/day
-0.021 0.57 +3.51 0.11 -0.033 0.23
Present smokers 
compared to non-
smokers
-0.22 0.17 +18.83 0.054 +0.033 0.78
The table gives the increase or decrease in enzyme activity per dose.
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not associated with CAT activity. Taken together, the 
results may suggest that CAT genetically determined 
high enzyme activity is protective of BC especially 
among non-smokers. While smoking had no statistically 
significant effect on CAT enzyme activity, smoking may 
change the cellular oxidant/antioxidant environment 
due to the presence of other compounds in the smoke, 
thereby masking the effect of the polymorphism we report 
among non-smokers. Whether the inconsistent effects 
observed among smokers and non-smokers are linked to 
Table 8: Associations between the studied genotypes and erythrocyte enzyme activities
Gene SNP Change in enzyme activity measured in U/g Hb (95% CI)
Cases (n=386) Controls (n=357) All (n=743)
CAT rs1001179
GG
GA
AA
P-value
a
0 (ref.)
-1.40 (-1.50;0.99)
-3.13 (-3.91;-2.35)
<0.0001
0 (ref.)
-1.79 (-2.23;-1.36)
-2.94 (-3.85;-2.03)
<0.0001
0 (ref.)
-1.59 (-1.89;-1.30)
-3.05 (-3.64;-2.45)
<0.0001
CAT rs12270780
GG
GA
AA
P-value
a
0 (ref.)
1.05 (0.62;1.47)
1.82 (1.04;2.59)
<0.0001
0 (ref.)
0.93 (0.46;1.40)
1.64 (0.47;2.81)
<0.0001
0 (ref.)
0.99 (0.67;1.30)
1.75 (1.10;2.40)
<0.0001
CAT rs769217
CC
CT
TT
P-value
a
0 (ref.)
-0.35 (-0.79;0.10)
-0.50 (-1.63;0.62)
0.25
0 (ref.)
-0.89 (-1.39;-0.40)
-1.35 (-2.72;0.03)
0.0007
0 (ref.)
-0.60 (-0.93;-0.26)
-0.86 (-1.74;0.01)
0.0007
GSR rs1002149
GG
GT
TT
P-value
a
0 (ref.)
1.69 (1.44;1.95)
4.25 (3.49;5.02)
<0.0001
0 (ref.)
2.14 (1.85;2.42)
3.83 (3.09;4.56)
<0.0001
0 (ref.)
1.90 (1.71;2.09)
4.02 (3.49;4.55)
<0.0001
SOD1 rs202445
AA
AG
GG
P-value
a
0 (ref.)
-3.17 (-31.90;25.56)
8.90 (-61.96;79.76)
0.94
0 (ref.)
7.99 (-22.05;38.03)
87.71 (12.86;162.56)
0.071
0 (ref.)
2.16 (-18.60;22.92)
46.70 (-4.75;98.16)
0.21
In this analysis, only individuals with missing values on genotypes and potentials confounders were excluded without 
regard to the match set.
a P-value for trend.
Table 9: Change in CAT enzyme activity in U/g Hb in relation to haplotype combination
Haplotype 
combination
GGC AGC P-valuea GAC P-valuea GGT P-valuea
GGC 0 (ref.) -1.8 <0.0001 0.3 0.25 -1.0 0.0004
AGC -3.3 <0.0001 -1.3 <0.0001 -2.7 <0.0001
GAC 0.1 0.68 -0.9 0.0030
GGT -1.6 <0.0001
a p-value for comparison to the wild-type haplotype (G-rs1001179A , G-rs12270780A, C-rs769217T). Variant alleles are in bold.
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the possible anti-estrogenic effect of smoking reported 
in some studies [59,60] is not clear but needs further 
investigation.
We used a prospective, nested case-control design, 
which together with complete follow-up minimizes 
selection bias. In addition, information on life style 
factors was collected at enrolment, which reduces the 
risk for differential misclassification between cases and 
controls. The study is fairly large to study main effects, it 
is homogenous and alcohol consumption is relatively high 
in the DCH cohort [61] making it suitable for studying 
gene-environment interactions. However, Danes including 
the Danish women in the present study have a relatively 
low intake of fruit and vegetables (Table 1), and therefore, 
the present study may have limited statistical power to 
detect effects of fruits and vegetables consumption on 
antioxidant enzyme activities. The genes were carefully 
selected based on known and predicted functionality. 
Nevertheless, we are aware that our study may not be large 
enough for some of the gene environment interactions, 
although we have previously found gene-environment 
interactions for PPARG and alcohol intake and ADH and 
alcohol intake in relation to BC in the present cohort 
[40,41].
Neither enzyme activities measured once at study 
entry nor genetically determined differences in enzyme 
activities were associated with risk of BC. There are 
two possible interpretations; either that antioxidant 
activity is not involved in breast carcinogenesis. 
Alternatively, genetically determined variations are 
small compared to the influence of lifestyle factors. 
However, smoking, alcohol intake and fruit and 
vegetable intake only correlated with the measured 
enzyme activities to a very limited extent. Thus, the 
genetically determined changes in the enzyme activities 
were larger than the effects of the lifestyle factors 
studied here. Our results therefore suggest that the 
antioxidant enzyme activities included here are not 
major determinants of BC risk.
MATERIALS AND METHODS
Subjects
The subjects were selected from the ongoing Danish 
DCH cohort study. The present study group has been 
described previously [40,41]. In short, 79,729 women aged 
50–64 years, born in Denmark, living in the Copenhagen 
or Aarhus areas and having no previous cancers at the 
time of invitation were invited to participate in the study 
between December 1993 and May 1997. A total of 29,875 
women accepted the invitation, corresponding to 37% of 
the invited women.
Study participants were followed up for diagnosis of 
BC from date of entry until either the date of diagnosis of 
cancer using record linkage to the Danish Cancer Registry 
until 2003 and afterwards by linkage to the Danish 
Pathology Databank, date of death, date of emigration, 
or April 27th, 2006, whichever came first. A total of 975 
women were diagnosed with BC during the follow-up 
period. For each case, one matched control was selected 
[40,41]. The control was cancer-free at the exact age at 
diagnosis of the case and was further matched on age at 
inclusion into the cohort (half-year intervals), use of HRT 
(current/former/never) and on certainty of postmenopausal 
status (known/probably postmenopausal) upon inclusion 
into the cohort [40,41]. 208 individuals were excluded 
because of failed genotyping or no buffy coat was 
available. Additionally 82 individuals were excluded 
because of missing information about one or more of the 
potential confounding variables. 254 individuals were 
excluded because of a missing partner in the case-control 
pair, due to the above mentioned exclusions leaving 703 
pairs for data analyses.
Data on covariates
From food frequency and lifestyle questionnaires, 
we obtained information on duration of school education, 
Table 10: IRR for BC for combinations of CAT/rs1001179 and SOD1/rs202445 genotypes
CAT/rs1001179
IRR (95% CI)a IRR (95% CI)b P-valuec
SOD1/rs202445
AA AG+GG AA AG+GG
GG 1.00 (ref.) 1.12 (0.83-1.50) 1.00 (ref.) 1.12 (0.83-1.53)
GA+AA 0.96 (0.74-1.23) 1.31 (0.94-1.83) 0.98 (0.75-1.26) 1.43 (1.01-2.01) 0.27
IRR: incidence rate ratio.
a Crude.
b Adjusted for parous/nulliparous, number of births, age at first birth, length of school education (low, medium, high), 
duration of HRT use (years), BMI (kg/m2) , previous benign breast disease and alcohol intake (10 g/day).
c P-value for interaction on a multiplicative scale.
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smoking status, HRT use, birth pattern (number of births 
and age at first birth), alcohol intake and diet. Body mass 
index (BMI) was computed based on measurements of 
height and weight at enrolment. Intake of alcohol was 
inferred from the food-frequency questionnaire and life-
style questionnaire as described in details in [40,41]. 
Abstainers were defined as those who reported no intake 
of alcohol on the food-frequency questionnaire and 
no drinking occasions on the lifestyle questionnaire. 
Findings on all known risk factors have been reported 
previously for both the entire DCH cohort, for a subset 
of the present study, and for the present study group 
[40,42–46].
Blood sampling and storage
From non-fasting participants a total of 30 ml blood 
was collected in citrated (2 x 10 ml) and plain (1 x 10 ml) 
Venojects from each participant. Plasma, serum, lymphocytes 
and erythrocytes were isolated and frozen at -20°C within 2 
hours. At the end of the day of collection, all samples were 
stored in liquid nitrogen, at -150°C.
Genotyping
DNA was isolated from frozen lymphocytes as 
described [62]. Generally, 100 mg DNA was obtained from 
107 lymphocytes. All polymorphisms were genotyped by 
KBioscience (KBioscience, Hoddesdon, United Kingdom) 
by PCR-based KASP™ genotyping assay (http:// 
www.lgcgenomics.com/). To confirm reproducibility, 
genotyping was repeated for 10 % of the samples yielding 
100% identical genotypes.
Selection of polymorphisms
Common, functional polymorphisms in SOD1, 
CAT and GSR were chosen with minor allele frequencies 
between 0.31 and 0.44 which is considered ideal when 
studying gene-environment interactions [63–65]. 
Functionality was either based on a literature search or 
using the http://manticore.niehs.nih.gov/snpinfo/snpfunc.
htm website [66], which is a web-based tool that predicts 
functionality of SNPs. SOD1/rs202445 is located in the 
regulatory region of the promotor [67]. GSR/rs1002149 
and CAT/rs1001179 are also located in the promoter 
region [58,67] at a transcription factor binding site [66]; 
and CAT/rs1001179 correlates with catalase activity 
[33,57,68]. CAT/rs769217 is located in exon 9 [58] at an 
exonic splicing site [66]; and CAT/rs12270780 is located 
in intron 2 (http://www.ncbi.nlm.nih.gov/projects/SNP/
snp_ref.cgi?rs=12270780) at a transcription factor binding 
site [66].
Erythrocyte enzyme activities
In a subset of the present cohort comprising 434 
case-control pairs, SOD, CAT and GR activities were 
determined spectrophotometrically in erythrocyte lysates 
on a Cobas Mira analyzer (F. Hoffmann-La Roche Ltd, 
Basel, Switzerland) according to Wheeler et al. [69]. This 
subset has been described in details elsewhere [31]. Intra- 
and interday CVs were 2,8% and 4,7% for GR, 6,8% and 
9,7% for SOD and 4,6% and 9% for CAT.
Statistical analyses
Deviation from Hardy-Weinberg equilibrium was 
assessed using a Chi square test.
Due to the study design using incidence density 
sampling of controls with match on age at diagnosis, 
matched logistic regression analyses leads to estimation 
of BC incidence rate ratio (IRR) [70] corresponding to a 
Cox proportional hazard model for the full cohort with 
age as the time axis. The associations between genotype, 
enzyme activity and BC are presented as crude IRR as 
well as adjusted for potential BC risk factors. Two-
sided 95% confidence intervals (CI) for the IRR were 
calculated based on Wald’s test of the Cox regression 
parameter, i.e. on the log RR scale. All models were 
adjusted for baseline values of risk factors for BC such 
as parity (entered as two variables; parous/nulliparous 
and number of births), age at first birth, length of school 
education (low, medium and high), duration of HRT use, 
alcohol intake and BMI. IRR was calculated separately 
for heterozygous and homozygous variant allele carriers. 
For all the SNPs, variant allele carriers were subsequently 
grouped for interaction analyses to improve the statistical 
power since no recessive effects were observed. For the 
different genetic variations, we investigated interactions 
with alcohol intake, smoking, and fruit and vegetables, 
using the likelihood ratio test.
A covariance model was used to determine the effects 
of fruits and vegetables, intake of alcohol and smoking on 
enzyme activity according to genotype. Enzyme activity 
was found to be normally distributed among the participants, 
and hence, the activity was entered untransformed as the 
dependent variable in the covariate models.
The procedures PHREG (Proportional Hazard 
Regression) and GLM (General Linear Model) in SAS, 
release 9.3; SAS Institute, (Cary, NC) were used for the 
matched logistic regression analyses and the covariance 
analyses, respectively.
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